10x Genomics TXGBehind cell research in the lab
1.30 % of fund value
Makes single-cell analysis instruments and reagents for biology research
DAOL US SMALL CAP FUND
Shows where this fund stands in its group. Not investment advice · Data as of 4 Nov 2026
DAOL-USSMALL invests through the master fund First Trust Small Cap Growth AlphaDEX® Fund (FYC) 97.68%
This fundDAOL-USSMALL
The fund that actually investsFirst Trust Small Cap Growth AlphaDEX® FundThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
10x Genomics TXG1.30%
Twist Bioscience TWST1.29%Data as of 20 Oct 2026 · Top 6 shown, the rest grouped as Other · per Yahoo Finance
Launched less than a year ago, so no 1-year rank yet
Each bar is one fund in the AIMC US Equity group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 4 Nov 2026
Past performance is not a guarantee of future results
| 1W | 2W | 1M | MAX |
|---|---|---|---|
| −1.12% | +0.36% | −1.43% | −6.56% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | · | · | · | · | · | · | · | −2.4 | −3.8 | −1.4 | +1.0 | · | −6.6* |
Not enough history yet
Largest drawdown in the selected period −9.55% Previous peak 27 Aug 2026 (NAV 9.9963) → Trough 19 Oct 2026 (NAV 9.0414) · Not back to the previous peak as of 4 Nov 2026
Currently −6.56% from the peak NAV of 9.9963 (27 Aug 2026)
Over 1 year, 84 funds have data · DAOL-USSMALL has no data for this period yet
กองทุนเน้นลงทุนในหน่วยลงทุนของ First Trust Small Cap Growth AlphaDEX® Fund (กองทุนหลัก) ในสกุลเงินดอลลาร์สหรัฐ (USD) เพียงกองทุนเดียว โดยเฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิของกองทุน ทั้งนี้ กองทุนหลักเป็นกองทุนอีทีเอฟ ซึ่งจดทะเบียนซื้อขายในตลาดหลักทรัพย์ The Nasdaq Stock… Its largest holdings are ชื่อหลักทรัพย์ FIRST TRUST SMALL CAP GROWTH 97.68% (fact sheet 31 Aug 2026)
Risk level 6 of 8 (High risk). Since 27 Aug 2026, its NAV has fallen as much as −9.55% from its peak.
Actual total expense ratio (TER) 1.96% a year, against a ceiling of 4.80%. Management fee 1.61%. Front-end fee 1.61%. Back-end fee 0.00%. (Fact sheet 31 Aug 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1 THB, subsequent purchases 1 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+2
Hedged at the manager's discretion. As of 31 Aug 2026, 86.81% of the value of its foreign investments was hedged
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
RingCentral RNG
Acadian Asset Management AAMI0.88%
NeoGenomics NEO0.87%
The Chefs' Warehouse CHEF0.80%
Aveanna Healthcare AVAH0.80%10x Genomics TXGMakes single-cell analysis instruments and reagents for biology research
Twist Bioscience TWSTMakes synthetic DNA on silicon chips for drug and genetics research
RingCentral RNGProvides cloud business phone systems, video meetings and team chat
US biotech company that develops gene therapies and immunotherapies for serious diseases
A US investment manager that uses quantitative models to manage money for institutional investors
NeoGenomics NEOUS cancer diagnostic labs serving doctors and drug companies
Hospitals, medicines and medical equipment
The Chefs' Warehouse CHEFUS company that delivers premium ingredients such as meat, cheese and seafood to restaurants and hotels
Maker of lubricants and specialty petroleum products, as well as renewable fuels
Aveanna Healthcare AVAHProvides home nursing and health care in the US, including for children
Based on the master fund's share of this fund's value (97.68% as of 31 Aug 2026) × each stock's weight in the master fund · stocks as of 20 Oct 2026 · Illustrations are for explanation only, not individual stock recommendations